Infectious Diseases and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.6 | Q1 | 89.4% | 1.660 | Q1 | 93.3% |
| 2024 | 5.3 | Q1 | 90.5% | 1.526 | Q1 | 92.5% |
| 2023 | 4.7 | Q1 | 85.5% | 1.351 | Q1 | 91.3% |
| 2022 | 5.4 | Q2 | 81.1% | 1.166 | Q1 | 89.4% |
| 2021 | 6.1 | Q2 | 84.9% | 1.141 | Q1 | 89.1% |
| 2020 | — | — | 1.399 | Q1 | 91.4% | |
| 2019 | — | — | 1.458 | Q1 | 92.2% | |
| 2018 | — | — | 1.714 | Q1 | 93.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2193-6382
ISSN
2193-8229
region
Western Europe
coverage
2012-2026